Metraipolis › archive › dc_87977a597ca2
Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42923586
- DOI
- 10.1210/jcemcr/luag249
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:44:38.687Z
- SHA-256 of the archived text
d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3- Stable URL of this page
https://metraipolis.com/documento/dc_87977a597ca2
How to cite
Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586 — Europe PMC (en), https://europepmc.org/article/MED/42923586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87977a597ca2 (Metraipolis archive dc_87977a597ca2, sha256 d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3)
BibTeX
@misc{dc87977a597ca2,
title = {Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42923586},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87977a597ca2; sha256 d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42923586. Agents can read the archived copy with the MCP tool read_document.